الرئيسية › سرطان الثدي › بنسلفانيا › Philadelphia
التجارب السريرية لـ سرطان الثدي في Philadelphia، PA
56 دراسات لـ سرطان الثدي تبحث عن مشاركين في مواقع داخل وحول Philadelphia (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
جارٍ التسجيلالمرحلة 3
- Consultants In Med Onco And Hema, Drexel Hill · على بُعد 7 ميل
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · على بُعد 22 ميل
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
- Alliance Cancer Specialists, Horsham · على بُعد 16 ميل
Study of AVZO-021 in Patients With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
جارٍ التسجيلالمرحلة 3
- Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
جارٍ التسجيلالمرحلة 3
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine - Chester County Hospital, West Chester · على بُعد 24 ميل
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
جارٍ التسجيلالمرحلة 3
- Clinical Trial Site, Horsham · على بُعد 16 ميل
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
جارٍ التسجيلالمرحلة 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
جارٍ التسجيلالمرحلة 3
- University of Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Jefferson Hospital Northeast, Philadelphia
- و 1 أخرى
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
جارٍ التسجيلالمرحلة 3
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · على بُعد 7 ميل
- Consultants In Medical Oncology and Hematology, P.C., Broomall · على بُعد 10 ميل
- و 1 أخرى
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
جارٍ التسجيلالمرحلة 1/2
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
جارٍ التسجيلالمرحلة 1/2
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
جارٍ التسجيلدراسة رصدية
- Abramson Cancer Center, Philadelphia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
جارٍ التسجيلالمرحلة 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- و 11 أخرى
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
جارٍ التسجيل
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
جارٍ التسجيل
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
جارٍ التسجيلالمرحلة 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
جارٍ التسجيل
- Fox Chase Cancer Center, Philadelphia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
جارٍ التسجيلالمرحلة 3
- Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital, Philadelphia
E-Mindfulness Approaches for Living After Breast Cancer
جارٍ التسجيلالمرحلة 3
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · على بُعد 8 ميل
- Chester County Hospital, West Chester · على بُعد 24 ميل
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Thomas Jefferson University Hospital, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
جارٍ التسجيلالمرحلة 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- Investigative Site #109, Philadelphia
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
جارٍ التسجيلالمرحلة 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
جارٍ التسجيل
- Abamson Cancer Center of the University of Pennsylvania, Philadelphia
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
جارٍ التسجيلالمرحلة 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
جارٍ التسجيلالمرحلة 3
- Rittenhouse Hematology/Oncology, Philadelphia
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Hospital of the University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania (U Penn), Philadelphia
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
جارٍ التسجيلالمرحلة الأولى المبكرة
- Hospital of the University of Pennsylvania, Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
B.Brilliant Revelation Comparision Study
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Pennsylvania Hospital, Center for Breast Imaging, Philadelphia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
جارٍ التسجيلالمرحلة 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- و 4 أخرى
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
جارٍ التسجيلالمرحلة 1
- University of Pennsylvania, Philadelphia
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
جارٍ التسجيلدراسة رصدية
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
FES BPET-DBT in Newly Diagnosed Breast Cancer
جارٍ التسجيلالمرحلة الأولى المبكرة
- University of Pennsylvania, Philadelphia
Safe and Explainable AI
جارٍ التسجيلدراسة رصدية
- Hospital of the University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
جارٍ التسجيلدراسة رصدية
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
جارٍ التسجيلالمرحلة 4
- Albert Einstein Healthcare Network, Philadelphia
[18F] F-GLN by PET/CT in Breast Cancer
جارٍ التسجيلالمرحلة 1
- University of Pennsylvania, Philadelphia
Prospective Breast Cancer Biospecimen Collection
جارٍ التسجيلدراسة رصدية
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
جارٍ التسجيل
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, Philadelphia
Surviving Daily Life
جارٍ التسجيلدراسة رصدية
- Thomas Jefferson University, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
جارٍ التسجيلالمرحلة 3
- University of Pennsylvania, Philadelphia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
جارٍ التسجيلدراسة رصدية
- Consultants in Medical Oncology and Hematology, P.C., Broomall · على بُعد 10 ميل
- Alliance Cancer Specialists, Horsham · على بُعد 16 ميل
Role of the Immune Environment in Response to Therapy in Breast Cancer
جارٍ التسجيلدراسة رصدية
- Abramson Cancer Center, Philadelphia
تجارب سرطان الثدي في مدن أخرى
- New York City, NY136 دراسات
- Houston, TX126 دراسات
- Boston, MA112 دراسات
- Nashville, TN81 دراسات
- Los Angeles, CA73 دراسات
- Edison, NJ68 دراسات
- St. Louis, MO64 دراسات
- Queens, NY64 دراسات
- Durham, NC64 دراسات
- Chicago, IL59 دراسات
- Dallas, TX55 دراسات
- Arlington, VA47 دراسات
دراسات أخرى في Philadelphia
- السرطان (جميع الأنواع)59 دراسات
- سرطان الرئة غير صغير الخلايا51 دراسات
- السرطان النقيلي46 دراسات
- سرطان البروستاتا44 دراسات
- سرطان القولون والمستقيم44 دراسات
- سرطان المبيض44 دراسات
- سرطان الرئة36 دراسات
- ابيضاض الدم النقوي الحاد34 دراسات
- قصور القلب31 دراسات
- سرطان بطانة الرحم28 دراسات
- الاكتئاب26 دراسات
- سرطان البنكرياس26 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.